BioCentury

12:38 AM GMT, Oct 9, 2012
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Top Story

Ardelyx, AZN in deal for NHE3 inhibitors

Ardelyx Inc. (Fremont, Calif.) granted AstraZeneca plc (LSE:AZN; NYSE:AZN) exclusive, worldwide

Read the full 114 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.